1-6 of 6
Gulsan Sucak
Close
Sort by
Journal Articles

Long-Term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-Center Real-Life Experience

A. Burhan Ferhanoglu, MD, Murat Özbalak, Ayse Salihoglu, MD, Teoman Soysal, MD, ihsan Karadoğan, Semra Paydas, MD, Evren Ozdemir, MD, Birol Yıldız, Nuri Karadurmuş, Leylagül Kaynar, Zeynep Arzu Yeğin, Ezgi Pınar Özbalak, Gülsan Sucak, Vildan Ozkocaman, MD, Pervin Topçuoğlu, Muhit Ozcan, MD, Elif Birtas, Hakan Goker, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5173.
https://doi.org/10.1182/blood.V130.Suppl_1.5173.5173
Published: 2017
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndrome (MDS) Patients at Lower Risk According to International Prognostic Scoring System (IPSS) : A Retrospective Study on Behalf of the Cmwp of the EBMT

Marie Robin, MD PhD, Porcher Raphael, Anja van Biezen, Liisa Volin, MD, Ghulam J. Mufti, DM, FRCP, FRCPath, Charles Craddock, MDPhD, Jurgen Finke, MD, Carlos Richard Espiga, Jakob Passweg, MD, Andrew Peniket, Johan Maertens, MD, Gulsan Sucak, MD, Tobias Gedde-Dahl, Antonin Vitek, Arnon Nagler, MD, Didier Blaise, MD, Dietrich Beelen, MD, Natacha Maillard, MD, Rainer Schwerdtfeger, MD, Simona Iacobelli, PhD, Theo de Witte, MD, Nicolaus Kroeger, MD
Journal: Blood
Blood (2014) 124 (21): 2530.
https://doi.org/10.1182/blood.V124.21.2530.2530
Published: 2014
Journal Articles

High-Dose Therapy and Autologous Stem Cell Transplantation for Extra-Nodal NK/T Lymphoma in Western Patients; A Study From the European Group for Blood and Marrow Transplantation (EBMT).

Christopher P Fox, MD, PhD, Ariane Boumendil, Herve Finel, Jian Jian Luan, Gulsan Sucak, MD, Didier Blaise, MD, Jurgen Finke, MD, Karl-Heinz Pflüger, MD, Hendrik Veelken, MD PhD, Norbert C Gorin, MD, Xavier Poiré, MD, Arnold Ganser, Norbert Schmitz, MD, Peter Dreger, MD, Anna Sureda, MD
Journal: Blood
Blood (2012) 120 (21): 3148.
https://doi.org/10.1182/blood.V120.21.3148.3148
Published: 2012
Journal Articles

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with T-Cell Acute Lymphoblastic Leukemia: A Survey From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Xavier Cahu, MD, Myriam Labopin, Sebastian Giebel, MD, Gerard Socie, MD, Pr, Dietrich Beelen, Renate Arnold, MD, Mauricette Michallet, MD, PhD, Noel Milpied, MD, Gulsan Sucak, Gunhan Gurman, MD, Slawomira Kyrcz-Krzemien, MD, PhD, Jakob R. Passweg, Ibrahim Yakoub-Agha, MD, PhD, Matthias Stelljes, MD, Jordi Esteve, MD, PhD, Mohamad Mohty, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 356.
https://doi.org/10.1182/blood.V120.21.356.356
Published: 2012
Journal Articles

Kiler Immunoglobulin Receptor(KIR) Ligands Are Associated with At Least Partial (HLA A*03, B*44) or Poorer (HLA B*51, C*04) Response to Thalidomide Among Patients with Multiple Myeloma Treated in Two Turkish Centers

Elif Suyani, MD, Sule Mine Bakanay, MD, Klara Dalva, MD, Ezgi Cakmak, MSc, Rauf Haznedar, MD, Gulsan Sucak, MD, Meral Beksac, MD
Journal: Blood
Blood (2012) 120 (21): 4904.
https://doi.org/10.1182/blood.V120.21.4904.4904
Published: 2012
Journal Articles

Does Heparin Have An Anti-Myeloma Effect? An Analysis On Individual Data From Three Randomized Studies of GIMEMA, Nordic and Turkish Myeloma Study Groups,

Meral Beksac, MD, Anders Waage, MD, PhD, Sara Bringhen, MD, Sigurdur Y Kristinsson, MD PhD, Gulsan Sucak, MD, Peter Gimsing, MD, PhD, Lupparelli Giulia, PhD, Tulin Firatli Tuglular, MD, Gunnar Juliusson, MD PhD, Antonio Palumbo, MD
Journal: Blood
Blood (2011) 118 (21): 3970.
https://doi.org/10.1182/blood.V118.21.3970.3970
Published: 2011